For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
4
views
0
references
 Top references
cited by
5
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To compare bevacizumab, ranibizumab, aflibercept, and laser treatment as primary therapies for retinopathy of prematurity (ROP) in terms of retreatment rate.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Ophthalmology
          Title: Ophthalmology
          Publisher: Elsevier BV
          ISSN (Electronic): 1549-4713
          ISSN (Print): 0161-6420
          Publication date (Electronic): Dec 2022
          Volume: 129
          Issue: 12
          Affiliations
          [1 ] Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
          [2 ] Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
          [3 ] Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Ophthalmology Department, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, United Kingdom.
          [4 ] Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom. Electronic address: enquiries@eye.ox.ac.uk.
          Article
          Publisher Item ID: S0161-6420(22)00522-X
          DOI: 10.1016/j.ophtha.2022.06.042
          PubMed ID: 35842190
          SO-VID: cb8575a5-2259-4da0-a5e0-cefcd3fbbbe6
          History

          Keywords: Anti-VEGF,Retinopathy of prematurity,Network meta-analysis,ROP,Laser
          Data availability:
          Keywords: Anti-VEGF, Retinopathy of prematurity, Network meta-analysis, ROP, Laser

          Comments

          Comment on this article